Related references
Note: Only part of the references are listed.Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans
P. J. Maver et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results
Philip E. Castle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer An Observational Cohort Study
Philip E. Castle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity
Helen Trottier et al.
CANCER RESEARCH (2010)
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
F. Xavier Bosch et al.
VACCINE (2008)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
N. W. J. Bulkmans et al.
LANCET (2007)
Bead-based multiplex genotyping of human papillomaviruses
M Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Pobascam, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women
NWJ Bulkmans et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
GP5+/6+PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes
AJC van den Brule et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Share Paper
